Clinical trial

Semaglutide for Smoking Cessation in Patients With Diabetes

NCT07059377

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-13

PhasePHASE3

Study timeline

Study start (actual)2026-02-13Date precision: day

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Nicotine Addictionunresolved

Tobacco Dependenceunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

Nicotine replacementDRUG

Sponsors & collaborators

Ottawa Heart Institute Research Corporationlead sponsor

Mapped research locations

OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07059377 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.